Page last updated: 2024-11-03

ono 1078 and Drug Withdrawal Symptoms

ono 1078 has been researched along with Drug Withdrawal Symptoms in 2 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamaoki, J1
Kondo, M1
Sakai, N1
Nakata, J1
Takemura, H1
Nagai, A1
Takizawa, T1
Konno, K1
Kinoshita, M1
Shiraishi, T1
Koga, T1
Ayabe, M1
Rikimaru, T1
Oizumi, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough:A Prospective, Open Label, Randomized and Placebo-Controlled Trial[NCT02655562]Phase 4200 participants (Anticipated)Interventional2016-04-30Suspended (stopped due to There are difficulties in recruiting patients)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for ono 1078 and Drug Withdrawal Symptoms

ArticleYear
Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
    American journal of respiratory and critical care medicine, 1997, Volume: 155, Issue:4

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Beclomethasone;

1997

Other Studies

1 other study available for ono 1078 and Drug Withdrawal Symptoms

ArticleYear
Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic patient treated with pranlukast.
    The Journal of allergy and clinical immunology, 1999, Volume: 103, Issue:3 Pt 1

    Topics: Anti-Asthmatic Agents; Asthma; Chromones; Churg-Strauss Syndrome; Female; Humans; Leukotriene Antago

1999